259 related articles for article (PubMed ID: 7564435)
1. Commissural dehiscence of Carpentier-Edwards mitral bioprostheses. Explant analysis and pathogenesis.
Nistal JF; Hurlé A; Gutiérrez JA; Mazorra F; Revuelta JM
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):688-95; discussion 695-6. PubMed ID: 7564435
[TBL] [Abstract][Full Text] [Related]
2. Structural valve deterioration in mitral replacement surgery: comparison of Carpentier-Edwards supra-annular porcine and perimount pericardial bioprostheses.
Eric Jamieson WR; Marchand MA; Pelletier CL; Norton R; Pellerin M; Dubiel TW; Aupart MR; Daenen WJ; Holden MP; David TE; Ryba EA; Anderson WN
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):297-304. PubMed ID: 10425003
[TBL] [Abstract][Full Text] [Related]
3. [A case report: Carpentier-Edwards porcine bioprosthesis malfunction due to the stent dehiscence at 17 years after the implantation in the mitral position].
Hayashi K; Nakano H; Sakamoto T; Okamura H
Kyobu Geka; 2000 Jan; 53(1):79-82. PubMed ID: 10639799
[TBL] [Abstract][Full Text] [Related]
4. Morphologic findings in explanted Hancock II porcine bioprostheses.
Butany J; Yu W; Silver MD; David TE
J Heart Valve Dis; 1999 Jan; 8(1):4-15. PubMed ID: 10096476
[TBL] [Abstract][Full Text] [Related]
5. Commissural dehiscence: a rare and peculiar cause of porcine valve structural deterioration.
Bottio T; Valente M; Rizzoli G; Tarzia V; Bisleri G; Pettenazzo E; Gerosa G; Thiene G
J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1017-22. PubMed ID: 17059917
[TBL] [Abstract][Full Text] [Related]
6. Use of the Carpentier-Edwards porcine bioprosthesis: assessment of a patient selection policy.
Louagie Y; Noirhomme P; Aranguis E; Eucher P; Vanruyssevelt P; Buche M; Dion R; Jaumin P; Schoevaerdts JC; Chalant CH
J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1013-24. PubMed ID: 1405658
[TBL] [Abstract][Full Text] [Related]
7. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
Jamieson WR; Gudas VM; Burr LH; Janusz MT; Fradet GJ; Ling H; Germann E; Lichtenstein SV
Eur J Cardiothorac Surg; 2009 Jan; 35(1):104-10. PubMed ID: 19056294
[TBL] [Abstract][Full Text] [Related]
8. Age as a determinant for selection of porcine bioprostheses for cardiac valve replacement: experience with Carpentier-Edwards standard bioprosthesis.
Jamieson WR; Tyers GF; Janusz MT; Miyagishima RT; Munro AI; Ling H; Burr LH; Tutassaura H
Can J Cardiol; 1991 May; 7(4):181-8. PubMed ID: 2070287
[TBL] [Abstract][Full Text] [Related]
9. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
[TBL] [Abstract][Full Text] [Related]
10. An eight-year experience with porcine bioprosthetic cardiac valves.
Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
[TBL] [Abstract][Full Text] [Related]
11. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations.
Bourguignon T; Bouquiaux-Stablo AL; Loardi C; Mirza A; Candolfi P; Marchand M; Aupart MR
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2004-2011.e1. PubMed ID: 24667021
[TBL] [Abstract][Full Text] [Related]
12. The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.
Jamieson WR; Allen P; Miyagishima RT; Gerein AN; Munro AI; Burr LH; Tyers GF
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):543-61. PubMed ID: 2308373
[TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of Carpentier-Edwards porcine bioprosthesis for rheumatic heart disease.
Yu HY; Ho YL; Chu SH; Chen YS; Wang SS; Lin FY
J Thorac Cardiovasc Surg; 2003 Jul; 126(1):80-9. PubMed ID: 12878942
[TBL] [Abstract][Full Text] [Related]
14. The third generation Carpentier-Edwards bioprosthesis: early results.
Relland J; Perier P; Lecointe B
J Am Coll Cardiol; 1985 Nov; 6(5):1149-54. PubMed ID: 4045039
[TBL] [Abstract][Full Text] [Related]
15. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
[TBL] [Abstract][Full Text] [Related]
16. Carpentier-Edwards porcine bioprostheses: clinical performance assessed by actual analysis.
Jamieson WR; Miyagishima RT; Burr LH; Lichtenstein SV; Fradet GJ; Janusz MT
J Heart Valve Dis; 2000 Jul; 9(4):530-5. PubMed ID: 10947046
[TBL] [Abstract][Full Text] [Related]
17. Comparison of reoperation findings of the Carpentier-Edwards (standard) bioprosthesis and the St Jude bioimplant (formerly Liotta) in the mitral position.
Yamak B; Ozsöyler ; Ulus AT; Kiziltepe U; Katircioğlu SF; Taşdemir O
Cardiovasc Surg; 1999 Dec; 7(7):730-4. PubMed ID: 10639048
[TBL] [Abstract][Full Text] [Related]
18. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.
Murakami T; Eishi K; Nakano S; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kito Y; Kawashima Y
J Heart Valve Dis; 1996 Jan; 5(1):45-9. PubMed ID: 8834725
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients.
Peterseim DS; Cen YY; Cheruvu S; Landolfo K; Bashore TM; Lowe JE; Wolfe WG; Glower DD
J Thorac Cardiovasc Surg; 1999 May; 117(5):890-7. PubMed ID: 10220680
[TBL] [Abstract][Full Text] [Related]
20. Porcine valves: Hancock and Carpentier-Edwards aortic prostheses.
Fann JI; Miller DC
Semin Thorac Cardiovasc Surg; 1996 Jul; 8(3):259-68. PubMed ID: 8843517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
